Editorial: Tumor-initiating cells: An influential paradigm for xenograft research

Neuro-Oncology

Volumn 12, Issue 6, 2010, Pages 519-

  James, C David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; BRAIN TUMOR; CANCER RESEARCH; CANCER STEM CELL; EDITORIAL; GLIOMA; HUMAN; MOUSE; NONHUMAN; NUDE MOUSE; SCID MOUSE; TUMOR XENOGRAFT; ANIMAL; DRUG SCREENING; MEDICAL RESEARCH; METHODOLOGY; NOTE; PATHOLOGY;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; NEOPLASTIC STEM CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77957082167     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq053     Document Type: Editorial

References (5)

1. Krigman MR, Manueldis EE. Distribution of fluorescent tracers in heterologously transplanted intracerebral tumors. Cancer Res. 24:1749-1759, 1964.
2. Rana MW, Pinkerton H, Thornton H, Nagy D. Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice. Proc Soc Exp Biol Med. 155:85-88, 1977.
3. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature. 432:396-401, 2004.
4. Yu L, Baxter PA, Voicu H, Gurusiddappa S, Zhao Y, Adesina A, Man TK, Shu Q, Zhang Y-J, Zhao X-M, Su JM, Perlaky L, Dauser R, Chintagumpala M, Lau CC, Blaney SM, Rao PH, Leung H-CE, Li XN. A clinical relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro-Oncology. 12:580-594, 2010.
5. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760, 2006.